Who owns ADAGIO THERAPEUTICS INC?
- Ticker: IVVD
- CUSIP Number: 00534a102
Tip: Access positions for across all investors
Analyze quarterly positions in Adagio Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Adagio Therapeutics stock
Who bought or sold ADAGIO THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Maverick Capital | 9.3M | $37M | 77% | Dec 2023 |
|
| M28 Capital Management | 9.2M | $36M | 0% | Dec 2023 |
|
| Alphabet | 5.7M | $22M | 0% | Dec 2023 |
|
| OrbiMed Advisors | 4.1M | $16M | -22% | Dec 2023 |
|
| 683 Capital Management | 3.6M | $14M | -10% | Dec 2023 |
|
| Vanguard Group | 2.5M | $9.9M | 1% | Dec 2023 |
|
| Redmile Group | 1.4M | $5.7M | 0% | Dec 2023 |
|
| Millennium Management | 456k | $1.8M | -58% | Dec 2023 |
|
| Jacobs Levy Equity Management | 358k | $1.4M | -14% | Dec 2023 |
|
| Charles Schwab Investment Management | 304k | $1.2M | 14% | Dec 2023 |
|
| Citigroup | 270k | $1.1M | -47% | Dec 2023 |
|
| Acuitas Investments | 209k | $822k | 0% | Dec 2023 |
|
| Jane Street | 194k | $763k | 520% | Dec 2023 |
|
| Squarepoint Ops | 102k | $403k | -50% | Dec 2023 |
|
| Balyasny Asset Management | 87k | $342k | 100% | Dec 2023 |
|
| a16z Perennial Management | 80k | $315k | 100% | Dec 2023 |
|
| Barclays | 72k | $285k | 100% | Dec 2023 |
|
| Two Sigma Investments | 57k | $224k | 100% | Dec 2023 |
|
| Goldman Sachs Group | 54k | $213k | 136% | Dec 2023 |
|
| Citadel Advisors | 47k | $186k | 100% | Dec 2023 |
|
| Bank of America Corporation | 45k | $176k | 1336% | Dec 2023 |
|
| Marquette Asset Management | 43k | $170k | 0% | Dec 2023 |
|
| Marshall Wace | 29k | $116k | 100% | Dec 2023 |
|
| Cubist Systematic Strategies | 26k | $101k | 227% | Dec 2023 |
|
| Bank of New York Mellon | 26k | $101k | 0% | Dec 2023 |
|
| JustInvest | 18k | $69k | -13% | Dec 2023 |
|
| Laurion Capital Management | 16k | $63k | 100% | Dec 2023 |
|
| UBS Group | 15k | $57k | 1158% | Dec 2023 |
|
| Jpmorgan Chase & Co | 13k | $52k | -37% | Dec 2023 |
|
| Mariner Wealth Advisors | 11k | $41k | 3% | Dec 2023 |
|
| Naples Global Advisors | 10k | $39k | -50% | Dec 2023 |
|
| Rhumbline Advisers | 7.3k | $29k | 0% | Dec 2023 |
|
| Advisor Group Holdings | 6.3k | $25k | 1260% | Dec 2023 |
|
| Point72 Asia | 1.8k | $7.0k | 100% | Dec 2023 |
|
| Royal Bank of Canada | 675.00 | $3.0k | 13400% | Dec 2023 |
|
| Wells Fargo & Company | 674.00 | $2.7k | -24% | Dec 2023 |
|
| Aspire Private Capital | 200.00 | $888.000000 | 0% | Mar 2024 |
|
| Glassman Wealth Services | 200.00 | $788.000000 | 0% | Dec 2023 |
|
| NISA Investment Advisors | 6.00 | $24.000000 | 0% | Dec 2023 |
|
| Farther Finance Advisors | 1.00 | $4.000000 | 100% | Dec 2023 |
|
Who sold out of Adagio Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Tang Capital Management | Sep 2023 | 367k | $623k |
| Shay Capital | Sep 2023 | 15k | $25k |
| Point72 Asset Management | Sep 2023 | 11k | $19k |
| Deutsche Bank Aktiengesellschaft | Sep 2023 | 3.0k | $5.0k |
| China Universal Asset Management | Sep 2023 | 2.8k | $5.0k |
| Simplex Trading | Sep 2023 | 198.00 | $0 |